全文获取类型
收费全文 | 38786篇 |
免费 | 3399篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 469篇 |
儿科学 | 1191篇 |
妇产科学 | 970篇 |
基础医学 | 4820篇 |
口腔科学 | 820篇 |
临床医学 | 4039篇 |
内科学 | 7599篇 |
皮肤病学 | 667篇 |
神经病学 | 3605篇 |
特种医学 | 1178篇 |
外科学 | 5596篇 |
综合类 | 580篇 |
一般理论 | 47篇 |
预防医学 | 3982篇 |
眼科学 | 1404篇 |
药学 | 2240篇 |
中国医学 | 29篇 |
肿瘤学 | 3034篇 |
出版年
2023年 | 213篇 |
2022年 | 327篇 |
2021年 | 637篇 |
2020年 | 461篇 |
2019年 | 614篇 |
2018年 | 797篇 |
2017年 | 642篇 |
2016年 | 683篇 |
2015年 | 855篇 |
2014年 | 1137篇 |
2013年 | 1864篇 |
2012年 | 2249篇 |
2011年 | 2434篇 |
2010年 | 1482篇 |
2009年 | 1394篇 |
2008年 | 2307篇 |
2007年 | 2323篇 |
2006年 | 2372篇 |
2005年 | 2291篇 |
2004年 | 2144篇 |
2003年 | 2026篇 |
2002年 | 1949篇 |
2001年 | 551篇 |
2000年 | 462篇 |
1999年 | 571篇 |
1998年 | 510篇 |
1997年 | 426篇 |
1996年 | 359篇 |
1995年 | 350篇 |
1994年 | 352篇 |
1993年 | 327篇 |
1992年 | 393篇 |
1991年 | 383篇 |
1990年 | 388篇 |
1989年 | 349篇 |
1988年 | 299篇 |
1987年 | 273篇 |
1986年 | 312篇 |
1985年 | 296篇 |
1984年 | 335篇 |
1983年 | 287篇 |
1982年 | 351篇 |
1981年 | 333篇 |
1980年 | 266篇 |
1979年 | 243篇 |
1978年 | 189篇 |
1977年 | 181篇 |
1976年 | 179篇 |
1975年 | 158篇 |
1974年 | 188篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
Rosendo A. Rodriguez MD PhD Fraser Rubens MD MSc Carlos D. Rodriguez Howard J. Nathan MD 《Journal of neuroimaging》2006,16(2):126-132
OBJECTIVE: The application of intensity thresholds for embolus detection with transcranial Doppler (TCD) can exclude from analysis an unrecognized proportion of high-intensity transient signals (HITS))whose intensities are below the threshold. The lack of consistent threshold criteria between clinical trials may explain part of the discrepancy in the reported HITS counts. We investigated the effect of choosing different thresholds on the sensitivity and specificity of detecting HITS during cardiopulmonary bypass (CPB). METHODS: Two observers independently analyzed TCD recordings from 8 patients under CPB. Doppler signals were classified as true HITS, equivocal HITS, artifacts, and Doppler speckles according to preestablished criteria. The relative intensity of Doppler signals was measured by two different methods (TCD software vs manual). Receiver Operating Characteristic curves determined the optimal threshold for each of the two intensity methods. RESULTS: Reviewers achieved agreement in 96% of 2190 Doppler signals (kappa = 0.90). Relative intensities calculated with the TCD-software method were 3 dB (95% CI: 3.0-3.4) higher than the manual method. The optimal threshold was found at 10 dB (sensitivity: 99%; specificity: 90.8%) with the software method and at 7 dB with the manual method (sensitivity: 96%; specificity: 83%). The use of an intensity threshold 2 dB higher than the optimal increased the rejection of true HITS by 8% and 14%, respectively. CONCLUSIONS: Using intensity thresholds higher than the optimal for embolus detection decreases HITS counts. Choosing a threshold depends on the type of method used for measuring the signal intensity. Uniform threshold criteria and comparative studies between different Doppler devices are necessary for making clinical trials more comparable. 相似文献
8.
Sami S Zoghbi H Umesha Shetty Masanori Ichise Masahiro Fujita Masao Imaizumi Jeih-San Liow Jay Shah John L Musachio Victor W Pike Robert B Innis 《Journal of nuclear medicine》2006,47(3):520-527
18F-2beta-Carbomethoxy-3beta-(4-chlorophenyl)-8-(2-fluoroethyl)nortropane (18F-FECNT), a PET radioligand for the dopamine transporter (DAT), generates a radiometabolite that enters the rat brain. The aims of this study were to characterize this radiometabolite and to determine whether a similar phenomenon occurs in human and nonhuman primate brains by examining the stability of the apparent distribution volume in DAT-rich (striatum) and DAT-poor (cerebellum) regions of the brain. METHODS: Two rats were infused with 18F-FECNT and sacrificed at 60 min. Extracts of brain and plasma were analyzed by high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometric (LC-MS) techniques. Two human participants and 3 rhesus monkeys were injected with 18F-FECNT and scanned kinetically, with serial arterial blood analysis. RESULTS: At 60 min after the injection of rats, 18F-FECNT accumulated to levels about 7 times higher in the striatum than in the cortex and cerebellum. The radiometabolite was distributed at equal concentrations in all brain regions. The LC-MS techniques identified N-dealkylated FECNT as a major metabolite in the rat brain, and reverse-phase HPLC detected an equivalent amount of radiometabolite eluting with the void volume. The radiometabolite likely was 18F-fluoroacetaldehyde, the product expected from the N-dealkylation of 18F-FECNT, or its oxidation product, 18F-fluoroacetic acid. The distribution volume in the cerebellum increased up to 1.7-fold in humans between 60 and 300 min after injection and 2.0 +/- 0.1-fold (mean +/- SD; n = 3) in nonhuman primates between 60 and 240 min after injection. CONCLUSION: An 18F-fluoroalkyl metabolite of 18F-FECNT originating in the periphery confounded the measurements of DAT in the rat brain with a reference tissue model. Its uniform distribution across brain regions suggests that it has negligible affinity for DAT (i.e., it is an inactive radiometabolite). Consistent with the rodent data, the apparent distribution volume in the cerebellum of both humans and nonhuman primates showed a continual increase at late times after injection, a result that may be attributed to entry of the radiometabolite into the brain. Thus, reference tissue modeling of 18F-FECNT will be prone to more errors than analysis with a measured arterial input function. 相似文献
9.
10.
This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized
by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment
and the belief that PE is a normal part of aging, that it has no effective treatment, or that it will resolve itself, few
men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods;
desensitizing drugs; off-label use of antidepressants, phosphodiesterase type 5 inhibitors, or à-blockers), the majority of
men with PE are not satisfied with their results. New pharmacologic drugs develped specifically for the treatment of PE are
undergoing evaluation in clinical trials. For example, recent clinical research studies have revealed on-demand administration
of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and
satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction
with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral
therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development
may provide benefits over those available. 相似文献